Almirall, S.A. (0O9B)
LSE
Closed
Oct 7, 2026
Day's Range
9.9752 wk Range
9.89Overview - 0O9B - Almirall, S.A.
Key Statistics
Valuation
Enterprise Value
1.81B
P/E (Trailing)
‪53.79‬
Price / Sales (TTM)
‪2.56‬
Price / Book
‪1.39‬
EV / EBITDA
‪11.67‬
Profitability
Gross Margin
‪185.11%‬
Profit Margin
‪-1.22%‬
Operating Margin
‪6.53%‬
Return on Assets
‪1.63%‬
Return on Equity
‪-0.76%‬
Ownership
Shares Outstanding
217.60M
Float
77.08M
Held by Insiders
‪60.15%‬
Held by Institutions
‪12.67%‬
Price stats
Beta
‪0.39‬
50-Day Avg
‪10.63‬
200-Day Avg
‪11.76‬
Dividends
Frequency
Annual
Market Cap - 0O9B - Almirall, S.A.
Peers - 0O9B - Almirall, S.A.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on LSE.
- 0O9BLSEAlmirall, S.A.2.32BMarket Cap-18.04%52-week change53.80P/E (Trailing)‪-1.22%‬Profit Margin
- HLNLSEHaleon plc2.88TMarket Cap-1.07%52-week change18.76P/E (Trailing)‪14.55%‬Profit Margin
- 0QFPLSEGedeon Richter Plc.1.74TMarket Cap+0.00%52-week change7.34P/E (Trailing)‪19.72%‬Profit Margin
- HIKLSEHikma Pharmaceuticals PLC332.26BMarket Cap-8.04%52-week change12.41P/E (Trailing)‪11.31%‬Profit Margin
- ROSELSERosebank Industries plc308.38BMarket Cap-14.42%52-week change—P/E (Trailing)‪-4.92%‬Profit Margin
- HCMLSEHUTCHMED (China) Limited187.71BMarket Cap-9.26%52-week change108.00P/E (Trailing)‪3.25%‬Profit Margin
- 0MTDLSESwedish Orphan Biovitrum AB158.42BMarket Cap+36.33%52-week change45.80P/E (Trailing)‪15.54%‬Profit Margin
Profile Summary - 0O9B - Almirall, S.A.
About
Almirall, S.A. is a Spanish pharmaceutical company specializing in medical dermatology, headquartered in Barcelona and founded in 1944. It focuses on researching, developing, manufacturing, and marketing innovative medicines to address unmet needs in skin health, particularly for conditions like psoriasis, atopic…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
